A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

Clinical trial NCT06282159 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06282159
Sponsor: Dianthus Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2024-02-23
Primary completion: 2025-07-28
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.